Antonio Donato

Antonio Donato has a diverse work experience spanning various industries. Antonio started their career at Farmalabor in 1999, working in production until 2001. Antonio then joined Grünenthal from 2002 to 2009, where they held roles in business development, marketing, and sales. In 2007, they also took up a position as an invited assistant at the University of Coimbra. Currently, they are the CEO of Tecnimede Group, a role they assumed in June 2022. Additionally, they are a board member of the company, a position they have held since December 2009. Antonio Donato's experience showcases their expertise in management, marketing, sales, and production within the pharmaceutical and medical sectors.

Antonio Donato pursued their education with a strong focus on both business and pharmaceutical sciences. From 1985 to 1990, they attended the Universidade de Coimbra, where they obtained a Graduate degree in Pharmaceutical Sciences. This laid the foundation for their understanding of the pharmaceutical industry. Later, from 2003 to 2005, they enrolled at the ISEG - Lisbon School of Economics & Management, where they pursued an MBA degree in Gestao. This further enhanced their business acumen and management skills. These educational experiences reflect Antonio Donato's dedication to acquiring knowledge and expertise in both pharmaceutical sciences and business administration.